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Background/Aims: There are few data on the effects of low hemoglobin levels on 
the left ventricle (LV) in patients without heart disease. The objective of this study 
was to document changes in the echocardiographic variables of LV structure and 
function after the correction of anemia without significant cardiovascular dis-
ease.
Methods: In total, 34 iron-deficiency anemia patients (35 ± 11 years old, 32 females) 
without traditional cardiovascular risk factors or cardiovascular disease and 34 
age- and gender-matched controls were studied. Assessments included history, 
physical examination, and echocardiography. Of the 34 patients with anemia en-
rolled, 20 were followed and underwent echocardiography after correction of the 
anemia.
Results: There were signif icant differences between the anemia and control 
groups in LV diameter, left ventricular mass index (LVMI), left atrial volume in-
dex (LAVI), peak mitral early diastolic (E) velocity, peak mitral late diastolic (A) 
velocity, E/A ratio, the ratio of mitral to mitral annular early diastolic velocity (E/
E’), stroke volume, and cardiac index. Twenty patients underwent follow-up echo-
cardiography after treatment of anemia. The follow-up results showed significant 
decreases in the LV end-diastolic and end-systolic diameters and LVMI, com-
pared with baseline levels. LAVI, E velocity, and E/E’ also decreased, suggesting a 
decrease in LV filling pressure.
Conclusions: Low hemoglobin level was associated with larger cardiac chambers, 
increased LV, mass and higher LV filling pressure even in the subjects without 
cardiovascular risk factors or overt cardiovascular disease. Appropriate correction 
of anemia decreased LV mass, LA volume, and E/E’.
Keywords: Anemia; Ventricular remodeling
INTRODUCTION
Anemia reduces tissue oxygen delivery and causes a 
compensatory cardiovascular response. In chronic 
anemia, the heart undergoes structural changes and 
develops functional impairment in response to the re-
duced hemoglobin [1]. Anemia is a common comorbid 
condition in heart failure patients, and multiple ob-
servational studies have demonstrated an independent 
association between lower hemoglobin and adverse 
clinical outcomes in such cases [2-4]. Chronic anemia 
is usually accompanied by increased cardiac mass [5,6], 
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but its association with diastolic dysfunction is not 
well understood. Several published studies support 
an association between anemia and left ventricular 
(LV) diastolic dysfunction in patients with diabetes, 
chronic kidney disease, or cardiovascular disease, but 
the results are conflicting [7-10]. There are few previ-
ous data on the effects of low hemoglobin levels on LV 
diastolic function and structure in patients without 
overt heart disease. The objective of this study was to 
document changes in the echocardiographic variables 
of LV structure and function associated with low he-
moglobin levels.
METHODS
Study population
Patients were enrolled prospectively from those ad-
mitted to Ewha Womans University Mokdong Hos-
pital, from June 2006 to September 2008 with estab-
lished iron-def iciency anemia without signif icant 
arrhythmia. Iron-deficiency was defined as having 
an abnormal value for at least two of three laboratory 
tests of iron status (erythrocyte protoporphyrin, trans-
ferrin saturation, serum ferritin) and iron-deficiency 
anemia was defined as iron-deficiency plus low he-
moglobin (< 12 g/dL) [11]. Exclusion criteria included a 
history of recurrent anemia episodes, diabetes melli-
tus, essential hypertension, risk factors (family history 
of ischemic heart disease, dyslipidemia, or smoking) 
or established cardiovascular disease. Then, 34 age- 
and gender-matched healthy individuals with normal 
hemoglobin concentrations (> 14 g/dL in males and 
> 12 g/dL in females) were recruited as controls. The 
controls were free from known diseases, as suggested 
by history, clinical examination, echocardiography, 
and basic laboratory investigations. Of the 34 patients 
with anemia enrolled, 20 were followed and under-
went echocardiography after correction of the anemia 
with oral iron supplements.
This study was approved by the Institutional Review 
Board of Ewha Womans University Mokdong Hospi-
tal. Written informed consent was obtained from all 
patients.
 
Echocardiography
Transthoracic echocardiography was performed using 
a commercially available imaging ultrasound system 
(Sonos 5500, Hewlett-Packard Co., Palo Alto, CA, USA) 
with harmonic imaging. All examinations were con-
ducted by experienced sonographers and were ana-
lyzed by two experienced observers who were blinded 
to the clinical data. Quantif ication of the chamber 
area was performed basically according to the recom-
mendations of the American Society of Echocardiog-
raphy [12]. The LV internal diameter, septal thickness, 
and LV posterior wall thickness (PWT) were measured 
at end-diastole, defined by the onset of the QRS com-
plex. The LV mass was calculated using the following 
formula [13]: 0.80 × 1.04 × [(LVEDD + LVST + PWT)3 - 
(LVEDD)3] + 0.6, where LVEDD is the left ventricular 
end-diastolic diameter, LVST is the left ventricular 
septal thickness. The LV mass was indexed to body 
surface area to obtain the left ventricular mass index 
(LVMI). The left atrial (LA) diameter was measured by 
two-dimensional guided M-mode echocardiography, 
obtained with the parasternal short-axis view at the 
base of the heart [14]. The LA volume was calculated 
using the formula for the biplane area-length method 
[15], and the left atrial volume index (LAVI) was ob-
tained by calculating the LA volume to body surface 
area ratio. Mitral inf low velocities were obtained by 
pulsed-wave Doppler in the apical four-chamber view 
with a 1 to 2 mm sample volume placed at the tips of 
the mitral valve leaflets. Mitral early (E) and late (A) in-
flow velocities and the deceleration time (DT) of the E 
velocity were measured. Using the pulsed-wave tissue 
Doppler image, early (E’) and late (A’) diastolic mitral 
annular velocities were obtained at the septal mitral 
annulus level in the apical four-chamber view with 
septal annulus movement aligned with the sample 
volume line. The ratio of early transmitral inf low to 
diastolic velocity of the mitral annuls (E/E’) was cal-
culated. The left ventricular outflow tract (LVOT) area 
was calculated from the LVOT diameter, assuming a 
circular orifice. The stroke volume was calculated as 
the product of the LVOT area and the time velocity in-
tegral of LVOT. The cardiac output was then derived, 
taking the 1/R-R interval as the heart rate. Cardiac 
output was indexed to body surface area to obtain car-
diac index.
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Statistical analysis
Continuous variables are expressed as means ± stan-
dard deviations, and categorical variables as numbers 
and proportions (%). To compare the groups, indepen-
dent Student t tests were used for continuous variables, 
and a chi-square test for categorical variables. Parame-
ters measured after correction of anemia were com-
pared with basal values using a paired t test. Correla-
tions between variables were assessed with the Pearson 
correlation test. A p value of < 0.05 was considered to 
indicate statistical significance.
RESULTS
Baseline characteristics of anemic patients and control 
subjects are summarized in Table 1. There was no sig-
nificant difference between the groups in age, gender, 
body mass index, systolic or diastolic blood pressure, 
heart rate, serum creatinine, serum triglycerides, or 
serum albumin. Serum cholesterol and mean hemo-
globin levels were lower in the anemia group than the 
controls. The mean values of ferritin, transferrin satu-
ration, mean corpuscular volume and mean corpuscu-
lar hemoglobin concentration in patients with anemia 
were lower than previous reference values.
The two-dimensional echocardiographic measure-
ments are shown in Table 2. The LVEDD and left ven-
tricular end-systolic diameter (LVESD), LV PWT, and 
LVMI were significantly elevated in the anemia group. 
The LV ejection fraction did not differ significantly 
between the groups. LAVI was increased in patients 
with anemia. Doppler measurements are shown in Ta-
ble 3. The peak E velocity, peak A velocity, E/E’ ratio, 
stroke volume, and cardiac index were elevated signifi-
cantly in the anemia group. There was no significant 
difference in DT, peak E’ velocity, or peak A’ velocity.
Of the 34 patients with anemia, 20 underwent fol-
low-up echocardiography after correction of the ane-
mia with iron replacement therapy and transfusion. 
The mean time between baseline and follow-up was 5.2 
± 3.9 months. Clinical features and laboratory findings 
of the patients with anemia after iron replacement 
therapy are shown in Table 4. There was no significant 
change in body mass index, systolic blood pressure, or 
diastolic blood pressure. The heart rate was signifi-
Table 1. Baseline characteristics of anemic patients and control subjects
Variable
Patients with anemia
(n = 34)
Control subjects
(n = 34)
p value
Age, yr   35 ± 11 35 ± 11 0.999
Gender, female    32 (94)  32 (94) 0.999
BMI, kg/m2   35.1 ± 10.7 32.7 ± 3.6 0.421
SBP, mmHg 113.8 ± 7.7  115.9 ± 7.3 0.270
DBP, mmHg 71.4 ± 5.1 71.0 ± 4.0 0.733
Heart rate, beats/min   74.3 ± 13.7 71.7 ± 11.3 0.387
Hemoglobin, g/dL   5.8 ± 1.4 13.0 ± 0.9  < 0.001 
Creatinine, mg/dL   0.73 ± 0.11 0.79 ± 0.16 0.071
Cholesterol, mg/dL 140.7 ± 33.4 167.0 ± 26.6 0.001
Triglycerides, mg/dL  72.0 ± 35.4 83.9 ± 35.9 0.188
Albumin, g/dL   4.1 ± 0.5 4.3 ± 0.5 0.196
Ferritin, ng/dL   4.3 ± 5.0 - -
Transferrin saturation, %    5.3 ± 6.9 - -
MCV, fL    65.3 ± 10.9 - -
MCHC, g/dL  28.3 ± 2.6 - -
Values are presented as mean ± SD or number (%).
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MCV, mean corpuscular volume; MCHC, 
mean corpuscular hemoglobin concentration.
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cantly lower on follow-up, and mean hemoglobin was 
increased significantly compared with the baseline 
level (5.8 ± 1.3 g/dL vs. 12.5 ± 1.4 g/dL; p < 0.001).
Echocardiographic variables of anemic patients on 
follow-up are shown in Table 5. The LVESD, LVEDD, 
and LVMI decreased significantly, as was the LAVI. 
The ejection fraction did not change. In the Doppler 
echocardiographic studies, peak E velocity, E/E’, stroke 
volume and cardiac index all decreased significantly 
and peak A velocity, DT, peak E’ velocity, and peak A’ 
velocity were unchanged. A correlation analysis be-
tween hemoglobin and echocardiographic variable 
changes after correction of anemia showed a signifi-
cant negative correlation between percent change in 
hemoglobin and change in E/E’ and between percent 
change in hemoglobin and percent change in E/E’ (p = 
0.003 and p = 0.012, respectively) (Fig. 1). However, 
there was no significant correlation between change 
in hemoglobin and LVEDD, LVESD, LVMI, LAVI, or 
cardiac index.
DISCUSSION
Anemia is highly prevalent in heart failure patients 
and is strongly associated with systolic dysfunction [16]. 
Table 2. Two-dimensional echocardiographic variables of anemic patients and control subjects
Variable
Patients with anemia
(n = 34)
Control subjects
(n = 34)
p value
LVEDD, mm  51.8 ± 3.9 47.2 ± 3.2 < 0.001
LVESD, mm  31.5 ± 3.7  27.8 ± 2.9 < 0.001
SWT, mm  8.8 ± 1.5    7.3 ± 1.2    0.084
PWT, mm  8.0 ± 1.3    7.3 ± 1.2    0.046
LVMI, g/m2   97.0 ± 24.7   74.3 ± 15.2  < 0.001
LAD, mm  37.3 ± 5.5  33.6 ± 3.8    0.002
LAVI, mL/m2  28.1 ± 9.1  18.3 ± 4.5  < 0.001
EF, % 63.6 ± 5.2  65.7 ± 4.1    0.070
Values are presented as mean ± SD.
LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; SWT, septal wall thickness; 
PWT, posterior wall thickness; LVMI, left ventricular mass index; LAD, left atrial diameter; LAVI, left atrial volume index; EF, 
ejection fraction.
Table 3. Doppler measurements of anemic patients and control subjects
Variable
Patients with anemia
(n = 34)
Control subjects
(n = 34)
p value
Peak E velocity, m/sec   1.0 ± 0.2   0.8 ± 0.2 < 0.001
Peak A velocity, m/sec   0.7 ± 0.2   0.6 ± 0.1   0.034
DT, ms 194.2 ± 27.0 195.0 ± 24.3    0.897
Peak E’ velocity, cm/sec 13.4 ± 3.1  12.7 ± 1.9    0.225
Peak A’ velocity, cm/sec  11.5 ± 1.5   8.8 ± 1.8    0.303
E/E'   8.1 ± 2.1   6.7 ± 1.3    0.002
Stroke volume, mL   76.1 ± 14.8   67.9 ± 12.7    0.018
Cardiac index, L/min/m2   3.6 ± 0.8    3.0 ± 0.6    0.007
Values are presented as mean ± SD.
E, mitral early diastolic; A, mitral late diastolic; DT, deceleration time of mitral inf low velocity; E’, mitral annular early 
diastolic; A’, mitral annular late diastolic.
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Treatment of anemia improved exercise capacity and 
symptoms in symptomatic heart failure patients [17-
19]. Anemia is also a known risk factor for cardiovas-
cular disease, even in the low-risk general population 
[20]. However, it is unclear whether the correction of 
anemia benefits cardiac function or geometry. In the 
present study, we observed a significant improvement 
in LV geometry including LV mass and cavity size 
and a decrease in LV filling pressure in patients with 
iron-deficiency anemia without overt cardiovascular 
disease after correction of the anemia.
Most studies have been based on indices of systolic 
function and LV mass, and the association of anemia 
with LV diastolic function has been conflicting. Bahl 
Table 4. Clinical features and laboratory findings of anemic patients (n = 20) before and after anemia correction
Variable Before anemia correction After anemia correction p value
Age, yr 37 ± 10 -
Gender, female   20 (100) -
BMI, kg/m2   22.0 ± 3.0 22.0 ± 2.9 0.910
SBP, mmHg  112.9 ± 8.3  110.9 ± 7.4 0.391
DBP, mmHg    70.9 ± 5.9 71.4 ± 5.3 0.787
Heart rate, beats/min      71.8 ± 12.9   64.5 ± 10.5 0.026
Hemoglobin, g/dL     5.8 ± 1.3  12.5 ± 1.4  < 0.001
Creatinine, mg/dL      0.73 ± 0.11   0.79 ± 0.16 0.071
Cholesterol, mg/dL    140.7 ± 33.4  167.0 ± 26.6 0.001
Triglycerides, mg/dL     72.0 ± 35.4   83.9 ± 35.9 0.188
Albumin, g/dL      4.1 ± 0.5   4.3 ± 0.5 0.196
Values are presented as mean ± SD or number (%).
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Table 5. Echocardiographic variables of anemic patients (n = 20) before and after anemia correction
Variable Before anemia correction After anemia correction p value
LVEDD, mm  51.8 ± 4.0  49.4 ± 3.7 0.002
LVESD, mm  31.6 ± 2.8 29.3 ± 3.0 0.001
LVMI, g/m2 100.6 ± 29.3   84.0 ± 22.8  < 0.001
LAD, mm  38.1 ± 6.6  35.3 ± 4.9 0.010
LAVI, mL/m2  30.6 ± 9.9  22.5 ± 6.4 0.001
EF, %  63.4 ± 4.4 64.6 ± 4.9 0.312
Peak E velocity, m/sec    1.1 ± 0.2   0.8 ± 0.2 0.002
Peak A velocity, m/sec    0.7 ± 0.2   0.6 ± 0.2 0.226
DT, ms   193.2 ± 28.8 208.5 ± 43.2 0.212
Peak E’ velocity, cm/sec  12.2 ± 2.0 11.4 ± 3.2 0.316
Peak A’ velocity, cm/sec  13.4 ± 1.9   8.9 ± 2.6 0.317
E/E’   8.5 ± 2.3   7.3 ± 1.4 0.002
Stroke volume, mL   75.4 ± 15.4   69.7 ± 12.6 < 0.001
Cardiac index, L/min/m2    3.4 ± 0.9   1.8 ± 0.3 < 0.001
Values are presented as mean ± SD.
LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVMI, left ventricular mass 
index; LAD, left atrial diameter; LAVI, left atrial volume index; EF, ejection fraction; E, mitral early diastolic; A, mitral late 
diastolic; DT, deceleration time of mitral inflow velocity; E’, mitral annular early diastolic; A’, mitral annular late diastolic.
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et al. [9] did not observe any consistent abnormality in 
diastolic function in anemic conditions. Srivastava et 
al. [7] found that diabetic patients with anemia showed 
increased LA area, E/E’ ratio, and E-to-propagation ve-
locity (E/Vp) ratio, compared with diabetic patients 
without anemia, but any causal relationship between 
anemia and diastolic dysfunction was uncertain. Nair 
et al. [8] reported that coronary artery disease with 
moderate and severe anemia was associated with dia-
stolic dysfunction, assessed by the mitral inf low pat-
tern.
We evaluated LV diastolic filling pressure using the 
LAVI and E/E’ ratio. The E/E’ ratio is used as an initial 
estimate of the LV filling pressure, particularly in pa-
tients with preserved systolic function. The LA volume 
can be viewed as a morphological expression of LV di-
astolic dysfunction, because the exposure of the LA to 
increased filling pressure results in its remodeling, 
which is reflected in the LA volume [21,22]. We found 
that anemia was strongly associated with LV filling 
pressure, as assessed by the E/E’ ratio and the LAVI. 
These functional and hemodynamic changes in the 
LV associated with anemia were improved by appro-
priate correction of the low hemoglobin level. Thus, 
our results suggest that increased LV filling pressure 
and enlarged LA may be important mediators in the 
pathway from anemia to heart failure and the changes 
of LV geometry and filling pressure can be recovered, 
at least partly, by appropriate correction of hemoglo-
bin levels.
Several mechanisms may explain the association be-
tween anemia and raised LV filling pressure. Adapta-
tion to an anemic state involves augmentation of the 
cardiac index and stroke volume [23]. This overall in-
crease in sympathetic and inotropic activity places ad-
ditional stress on the myocardium, perhaps leading to 
remodeling of the myocytes and vasculature [9]. Addi-
tionally, studies on the coronary blood flow in anemic 
patients have shown a decrease in myocardial oxygen 
consumption despite an increase in myocardial work-
load and oxygen extraction [9]. As myocardial isch-
emia, as exemplified by coronary artery disease, is a 
well-established cause of diastolic dysfunction and in-
creased LV filling pressure [24], the inf luence of hy-
poxia on patients with anemia may have a similar ef-
fect. Interestingly, DT and peak E’ velocity, which are 
parameters of LV relaxation [25], did not differ between 
anemic patients and the control group and did not 
change after correction of anemia in our study. Thus, 
we suggest that increased LV filling pressure, result-
ing from the hyperdynamic status, may be more im-
portant than LV relaxation in causing the increase in 
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Figure 1. Scatter plot showing the correlation (A) between the percent change in hemoglobin level and change in the ratio of 
early transmitral inflow to diastolic velocity of the mitral annuls (E/E’), and (B) between the percent change of hemoglobin 
level and the percent change of E/E’ in the anemic patients after correction of anemia.
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E/E’ and LV structural changes in anemic patients.
Our results also are consistent with previous reports 
in which patients with anemia tended to be in a hyper-
dynamic state [9,23]. These patients had significantly 
higher stroke volumes and cardiac indices. Similarly, 
the LV mass and diameter were also increased signifi-
cantly in these patients. Various factors have been im-
plicated to explain this hyperdynamic state. Increased 
LVEDD suggested a role for the Frank-Starling mech-
anism in the hyperdynamic state of anemia [9]. More-
over, the presence of a significantly reduced systemic 
vascular resistance may contribute to the hyperdy-
namic state in such patients [9]. Classically, anemia 
has been associated with eccentric LV growth, charac-
terized by a proportional increase in the LV diameter 
and wall thickness [6,26]. Our results suggest that the 
pattern of LV structural change associated with ane-
mia involves an increase in both wall thickness and in 
LV cavity size.
Hemoglobin level was associated with structural 
changes in LA and LV, as well as the change in E/E’, 
which reflects LV filling pressure and LA pressure, but 
the values were all within normal ranges during the 
follow-up period. However, there were significant seri-
al changes during follow-up, even though the fol-
low-up duration was not long in this study. Thus, a 
further long-term effect of anemia on LV may be more 
extensive and this may be worth considering when 
managing heart failure patients with anemia. After 
correcting the anemia, only changes in the E/E’ ratio 
were negatively related to changes in the hemoglobin 
level. This indicates that the LV filling pressure, as-
sessed by the E/E’ ratio, may be the best method of 
predicting the current status of the LV, which is influ-
enced by hemoglobin changes.
Limitations
We believe that our study helps clarify the role of 
anemia in cardiac function and structure, but several 
limitations should be mentioned. First, our popula-
tion was composed largely of young females, and our 
results may not be pertinent to males or to other age 
groups. Second, the number of patients who com-
pleted echocardiographic follow-up in the study was 
relatively small. Thus, there were limitations in terms 
of performing multivariate analyses. Third, among 
the baseline characteristics, cholesterol levels showed 
significant differences between the anemic patients 
and controls. Additionally, heart rate and cholesterol 
level changed significantly in the studied population 
during the follow-up period. These factors may also 
have affected the results. Thus, further larger-scaled 
studies are warranted to reduce the effects of these 
confounding factors. Fourth, our population was 
composed totally of iron-deficiency anemia, and it 
is unclear whether our findings are applicable to pa-
tients with other causes of anemia. Fifth, most of the 
patients in our population demonstrated severe ane-
mia, with hemoglobin as low as 3.3 g/dL, so we could 
not leave them without treatment for ethical reasons. 
Thus, there were no controls with uncorrected low he-
moglobin levels on follow-up.
In conclusion, an association between anemia and 
LV structure and filling pressure was found in this 
study. The LVEDD, LVESD, LVMI, LAVI, and E/E’ ratio 
changed significantly after appropriate correction of 
the low hemoglobin levels in anemia patients without 
traditional cardiovascular risk factors or cardiovascu-
lar disease. These findings support the notion that the 
correction of anemia might improve LV structure and 
function.
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